Cargando…
eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935066/ http://dx.doi.org/10.1016/j.gim.2022.01.223 |
| _version_ | 1784671968283328512 |
|---|---|
| author | Manjrekar, Kriti Freeman, Mary Hedstrom, Karli Fierro, Luca Naik, Hetanshi Diaz, George Balwani, Manisha Ganesh, Jaya |
| author_facet | Manjrekar, Kriti Freeman, Mary Hedstrom, Karli Fierro, Luca Naik, Hetanshi Diaz, George Balwani, Manisha Ganesh, Jaya |
| author_sort | Manjrekar, Kriti |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8935066 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89350662022-03-21 eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials Manjrekar, Kriti Freeman, Mary Hedstrom, Karli Fierro, Luca Naik, Hetanshi Diaz, George Balwani, Manisha Ganesh, Jaya Genet Med Article Published by Elsevier Inc. 2022-03 2022-03-21 /pmc/articles/PMC8935066/ http://dx.doi.org/10.1016/j.gim.2022.01.223 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Manjrekar, Kriti Freeman, Mary Hedstrom, Karli Fierro, Luca Naik, Hetanshi Diaz, George Balwani, Manisha Ganesh, Jaya eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials |
| title | eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials |
| title_full | eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials |
| title_fullStr | eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials |
| title_full_unstemmed | eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials |
| title_short | eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials |
| title_sort | ep187: decentralization of clinical trials in the era of covid-19: implications for rare disease trials |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935066/ http://dx.doi.org/10.1016/j.gim.2022.01.223 |
| work_keys_str_mv | AT manjrekarkriti ep187decentralizationofclinicaltrialsintheeraofcovid19implicationsforrarediseasetrials AT freemanmary ep187decentralizationofclinicaltrialsintheeraofcovid19implicationsforrarediseasetrials AT hedstromkarli ep187decentralizationofclinicaltrialsintheeraofcovid19implicationsforrarediseasetrials AT fierroluca ep187decentralizationofclinicaltrialsintheeraofcovid19implicationsforrarediseasetrials AT naikhetanshi ep187decentralizationofclinicaltrialsintheeraofcovid19implicationsforrarediseasetrials AT diazgeorge ep187decentralizationofclinicaltrialsintheeraofcovid19implicationsforrarediseasetrials AT balwanimanisha ep187decentralizationofclinicaltrialsintheeraofcovid19implicationsforrarediseasetrials AT ganeshjaya ep187decentralizationofclinicaltrialsintheeraofcovid19implicationsforrarediseasetrials |